RANKINGS

POPULAR STOCKS

Perspective Therapeutics, Inc.

NYSE American:CATX

Location

United States

Market Cap

USD 256.83 M

Share Price

USD 3.46

Avg Daily Volume

922,233

Change (1 day)

0.29%

Change (1 year)

-67.51%

Change (YTD)

8.46%

Perspective Therapeutics, Inc. Receivables for the year ending December 31, 2024: USD 116.00 K

Perspective Therapeutics, Inc. Receivables is USD 116.00 K for the year ending December 31, 2024, a -90.13% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Perspective Therapeutics, Inc. Receivables for the year ending December 31, 2023 was USD 1.18 M, a -13.79% change year over year.
  • Perspective Therapeutics, Inc. Receivables for the year ending December 31, 2022 was USD 1.36 M, a -15.24% change year over year.
  • Perspective Therapeutics, Inc. Receivables for the year ending June 30, 2022 was USD 1.61 M, a -20.12% change year over year.
  • Perspective Therapeutics, Inc. Receivables for the year ending June 30, 2021 was USD 2.01 M, a -1.52% change year over year.
Key data
Date Receivables Inventory Current Assets Property, Plant, Equipment (Net)
Market news
NYSE American: CATX

Perspective Therapeutics, Inc.

CEO Mr. Johan M. Spoor
IPO Date Nov. 10, 2005
Location United States
Headquarters 350 Hills Street
Employees 138
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
🩺 Medical Instruments
⚛️ Nuclear
💻 Telehealth
Description

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

Similar companies

BSX

Boston Scientific Corporation

USD 101.30

-0.07%

SHL.DE

Siemens Healthineers AG

USD 53.26

0.96%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

RGC

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

NTRA

Natera, Inc.

USD 171.86

0.52%

LH

Laboratory Corporation of America Holdings

USD 261.88

0.19%

BAX

Baxter International Inc.

USD 29.99

0.64%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 36.56

0.20%

ICLR

ICON Public Limited Company

USD 146.48

2.02%

ASND

Ascendis Pharma A/S

USD 176.90

3.63%

EXAS

Exact Sciences Corporation

USD 53.02

1.30%

CTEC.L

ConvaTec Group Plc

USD 3.81

1.16%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.10

-0.68%

GH

Guardant Health, Inc.

USD 49.14

-2.83%

DIA.MI

DiaSorin S.p.A.

USD 108.71

1.66%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.61

-0.28%

LNTH

Lantheus Holdings, Inc.

USD 79.19

0.25%

688617.SS

APT Medical Inc.

USD 38.32

1.54%

ADMA

ADMA Biologics, Inc.

USD 17.74

-2.15%

TMDX

TransMedics Group, Inc.

USD 123.56

-0.36%

LAURUSLABS.NS

Laurus Labs Limited

USD 7.51

0.83%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.63

-0.48%

INSP

Inspire Medical Systems, Inc.

USD 130.91

0.93%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.82

0.10%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.94

0.32%

PFIZER.NS

Pfizer Limited

USD 64.46

-1.31%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.66

-0.23%

ERIS.NS

Eris Lifesciences Limited

USD 18.78

-6.20%

LIVN

LivaNova PLC

USD 45.51

0.75%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.94

1.21%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.18

0.95%

VCYT

Veracyte, Inc.

USD 26.39

-1.60%

BAVA.CO

Bavarian Nordic A/S

USD 26.83

0.43%

VITR.ST

Vitrolife AB (publ)

USD 14.17

-2.33%

QDEL

QuidelOrtho Corporation

USD 28.03

-1.06%

NVCR

NovoCure Limited

USD 16.69

-0.66%

HRMY

Harmony Biosciences Holdings, Inc.

USD 31.89

-1.82%

0853.HK

MicroPort Scientific Corporation

USD 1.00

-0.13%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.76

-0.53%

CERT

Certara, Inc.

USD 10.54

-0.28%

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

USD 3.13

2.31%

688289.SS

Sansure Biotech Inc.

USD 2.83

2.01%

ARQT

Arcutis Biotherapeutics, Inc.

USD 13.82

1.10%

INDGN.NS

Indegene Limited

USD 6.66

0.70%

ADPT

Adaptive Biotechnologies Corporation

USD 10.38

-0.86%

002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

USD 1.82

-0.37%

605507.SS

Guobang Pharma Ltd.

USD 2.79

1.77%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.51

0.67%

NOVO-B.CO

Novo Nordisk A/S

USD 73.32

-2.33%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

StockViz Staff

June 22, 2025

Any question? Send us an email